Insiders · Profile

AH Bio Fund II, L.P.

10% owner at Scribe Therapeutics. Filing since 27 Jul 2026. CIK 0001725721

Company

Date

Role

Action

Shares

Amount

Of holding

SCTX Scribe Therapeutics, Inc.

27 Jul 2026

10% owner

Bought

333,333

$5.00M

16.2%

1 decision on file.